CLBT Earnings & Financial Statements
Cellebrite DI Ltd.
$11.24
+$0.41(+3.79%)
40
Overall
35
Value
27
Tech
60
Quality
Market Cap
$2.72B
Volume
1.73M
52W Range
$9.58 - $19.98
Target Price
$15.36
CLBT earnings and financial statements: Cellebrite DI Ltd.'s income statement, balance sheet and cash flow statement, annual and quarterly.
CLBT Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $475.68M | -$401.20M | $325.11M | $270.65M | $246.25M |
| Cost of revenue | $75.17M | $62.59M | $53.23M | $50.75M | $42.56M |
| Operating income | $66.48M | -$745.50M | $33.24M | $1.04M | $13.82M |
| EBITDA | $100.17M | -$404.91M | -$66.66M | $129.95M | $89.31M |
| Net income | $78.33M | -$419.63M | -$81.10M | $120.81M | $71.40M |
| EPS (diluted) | $0.31 | $-1.35 | $-0.43 | $0.59 | $0.44 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $938.85M | $690.57M | $532.88M | $403.29M | $339.78M |
| Total liabilities | $454.53M | $354.55M | $498.67M | $329.43M | $413.13M |
| Shareholders’ equity | $484.32M | $336.02M | $34.21M | $73.86M | -$73.35M |
| Cash and equivalents | $124.46M | $191.66M | $189.52M | $87.64M | $145.97M |
| Long-term debt | $18.67M | $6.84M | $54.12M | $10.35M | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $173.54M | $132.17M | $102.06M | $20.58M | $36.05M |
| Free cash flow | $160.32M | $121.56M | $94.14M | $20.58M | $36.05M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLBT | $11.24 | +3.8% | 1.73M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |